Financhill
Back

Bicycle Therapeutics PLC 10K Form

Sell
17

BCYC
Bicycle Therapeutics PLC

Last Price:
23.73
Seasonality Move:
18.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive BCYC News And Ratings

See the #1 stock for the next 7 days that we like better than BCYC

BCYC Financial Statistics

Sales & Book Value

Annual Sales: $26.98M
Cash Flow: $-40.27M
Price / Cash Flow: 0
Annual Sales: $12.04
Price / Book: 1.95

Profitability

EPS (TTM): -3.29000
Net Income (TTM): $-166.28M
Gross Margin: --
Return on Equity: -29.19%
Return on Assets: -21.68%

Bicycle Therapeutics PLC Earnings Forecast

Key Bicycle Therapeutics PLC Financial Ratios

  • The Research & Development expenses have been 580.13% of Revenue.
  • The Interest Expense is -1.81% of Operating Income.
  • The Net Earning history of BCYC is -669.72% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 1 years.

Bicycle Therapeutics PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BCYC
CUSIP: 088786
Website: bicycletherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 17.13
Quick Ratio: 16.82

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BCYC Technical Analysis vs Fundamental Analysis

Sell
17
Bicycle Therapeutics PLC (BCYC) is a Sell

Is Bicycle Therapeutics PLC a Buy or a Sell?